Skip to main content

Table 3 Treatment at recurrence

From: Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC

CT 1° drug Frequency %
 Cisplatin 8 33.3
 Carboplatin 16 66.7
CT 2° drug Frequency %
 Etoposide 3 12.5
 Paclitaxel 9 37.5
 Pemetrexed 3 12.5
 Gemcitabine 5 20.8
 Vinorelbine 4 16.7
CT schedule Frequency %
 Weekly 10 41.7
 Every three weeks 14 58.3
Timing of CRT Frequency %
 Concomitant 18 75.0
 Sequential 6 25.0
Total RT dose Mean Range
  59.5 50–66
Timing from CRT to Durvalumab (days) Mean Range
  29 5–90